Bath & Body Works’ (BBWI) Hold Rating Reiterated at Argus

Bath & Body Works (NYSE:BBWIGet Free Report)‘s stock had its “hold” rating restated by stock analysts at Argus in a research note issued on Friday,Benzinga reports.

A number of other brokerages have also issued reports on BBWI. Morgan Stanley decreased their target price on shares of Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a research note on Thursday, November 21st. Telsey Advisory Group reaffirmed an “outperform” rating and issued a $42.00 target price on shares of Bath & Body Works in a research report on Monday, November 25th. Wells Fargo & Company upgraded Bath & Body Works from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $42.00 to $48.00 in a report on Friday. Deutsche Bank Aktiengesellschaft increased their price objective on Bath & Body Works from $51.00 to $52.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. Finally, TD Cowen boosted their target price on shares of Bath & Body Works from $42.00 to $48.00 and gave the stock a “buy” rating in a research report on Thursday, December 12th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and ten have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $43.06.

Get Our Latest Stock Report on Bath & Body Works

Bath & Body Works Stock Down 0.9 %

Shares of Bath & Body Works stock traded down $0.33 during midday trading on Friday, hitting $36.64. The company’s stock had a trading volume of 265,555 shares, compared to its average volume of 2,704,398. Bath & Body Works has a 1-year low of $26.20 and a 1-year high of $52.99. The firm has a market capitalization of $7.94 billion, a P/E ratio of 8.94, a PEG ratio of 1.43 and a beta of 1.82. The stock has a 50-day simple moving average of $35.60 and a 200-day simple moving average of $33.81.

Bath & Body Works (NYSE:BBWIGet Free Report) last announced its quarterly earnings data on Monday, November 25th. The company reported $0.49 EPS for the quarter, topping analysts’ consensus estimates of $0.46 by $0.03. The firm had revenue of $1.61 billion during the quarter, compared to analyst estimates of $1.58 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The business’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same period last year, the company posted $0.48 EPS. As a group, sell-side analysts predict that Bath & Body Works will post 3.26 earnings per share for the current year.

Institutional Investors Weigh In On Bath & Body Works

Several hedge funds have recently made changes to their positions in BBWI. Diversified Trust Co acquired a new position in Bath & Body Works in the 4th quarter valued at approximately $455,000. Bard Financial Services Inc. raised its stake in shares of Bath & Body Works by 107.4% in the fourth quarter. Bard Financial Services Inc. now owns 26,750 shares of the company’s stock valued at $1,037,000 after purchasing an additional 13,850 shares in the last quarter. Everence Capital Management Inc. acquired a new position in shares of Bath & Body Works in the fourth quarter valued at $260,000. GAMMA Investing LLC boosted its stake in Bath & Body Works by 78.7% during the fourth quarter. GAMMA Investing LLC now owns 4,434 shares of the company’s stock worth $172,000 after buying an additional 1,953 shares in the last quarter. Finally, Versant Capital Management Inc increased its holdings in Bath & Body Works by 161.7% in the 4th quarter. Versant Capital Management Inc now owns 2,141 shares of the company’s stock valued at $83,000 after buying an additional 1,323 shares during the period. Institutional investors own 95.14% of the company’s stock.

Bath & Body Works Company Profile

(Get Free Report)

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.

See Also

Analyst Recommendations for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.